These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 19394290)

  • 1. Systems biology makes it personal.
    Brynildsen MP; Collins JJ
    Mol Cell; 2009 Apr; 34(2):137-8. PubMed ID: 19394290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances and challenges in the use of biomarkers in clinical trials.
    Chabner B
    Clin Adv Hematol Oncol; 2008 Jan; 6(1):42-3. PubMed ID: 18322440
    [No Abstract]   [Full Text] [Related]  

  • 3. Network-based drugs and biomarkers.
    Erler JT; Linding R
    J Pathol; 2010 Jan; 220(2):290-6. PubMed ID: 19921715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bibliography. Current world literature. Cancer biology.
    Curr Opin Oncol; 2005 Jan; 17(1):67-82. PubMed ID: 15810123
    [No Abstract]   [Full Text] [Related]  

  • 5. Advances in biomarkers for targeted agents.
    Maitland ML
    Clin Adv Hematol Oncol; 2011 Sep; 9(9):688-90. PubMed ID: 22402514
    [No Abstract]   [Full Text] [Related]  

  • 6. The search for optimal response prediction in cancer leads to a personalized approach.
    Van Cutsem E; Ciardiello F
    Target Oncol; 2010 Mar; 5(1):3-4. PubMed ID: 20349283
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacology, pharmacogenetics, and pharmacoepidemiology: three ps of individualized therapy.
    Dawood S
    Cancer Invest; 2009 Oct; 27(8):809-15. PubMed ID: 19731103
    [No Abstract]   [Full Text] [Related]  

  • 8. Cancer Cell Line Encyclopedia launched by Novartis and Broad Institute.
    Marum L
    Future Med Chem; 2012 May; 4(8):947. PubMed ID: 22826900
    [No Abstract]   [Full Text] [Related]  

  • 9. Evaluation of chemoresponse assays as predictive markers.
    Korn EL; Freidlin B
    Br J Cancer; 2015 Feb; 112(4):621-3. PubMed ID: 25584494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress in molecular biology and translational science. Preface.
    Ruddon RW
    Prog Mol Biol Transl Sci; 2010; 95():xi. PubMed ID: 21075325
    [No Abstract]   [Full Text] [Related]  

  • 11. Nested effects models for learning signaling networks from perturbation data.
    Fröhlich H; Tresch A; Beissbarth T
    Biom J; 2009 Apr; 51(2):304-23. PubMed ID: 19358219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclooxygenase-2 inhibitors down-regulate osteopontin and Nr4A2-new therapeutic targets for colorectal cancers.
    Zagani R; Hamzaoui N; Cacheux W; de Reyniès A; Terris B; Chaussade S; Romagnolo B; Perret C; Lamarque D
    Gastroenterology; 2009 Oct; 137(4):1358-66.e1-3. PubMed ID: 19549529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional transcriptomics: an experimental basis for understanding the systems biology for cancer cells.
    Schäfer R; Tchernitsa OI; Györffy B; Serra V; Abdul-Ghani R; Lund P; Sers C
    Adv Enzyme Regul; 2007; 47():41-62. PubMed ID: 17335873
    [No Abstract]   [Full Text] [Related]  

  • 14. Bioactive peptides, networks and systems biology.
    Boonen K; Creemers JW; Schoofs L
    Bioessays; 2009 Mar; 31(3):300-14. PubMed ID: 19260025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network medicine.
    Pawson T; Linding R
    FEBS Lett; 2008 Apr; 582(8):1266-70. PubMed ID: 18282479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Now's the time to find biomarkers on purpose.
    Auman JT; McLeod HL
    Ann Oncol; 2010 Feb; 21(2):193-194. PubMed ID: 20047974
    [No Abstract]   [Full Text] [Related]  

  • 17. Epigenetic deregulation of DNA repair and its potential for therapy.
    Hegi ME; Sciuscio D; Murat A; Levivier M; Stupp R
    Clin Cancer Res; 2009 Aug; 15(16):5026-31. PubMed ID: 19671858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An anticancer effect of curcumin mediated by down-regulating phosphatase of regenerating liver-3 expression on highly metastatic melanoma cells.
    Wang L; Shen Y; Song R; Sun Y; Xu J; Xu Q
    Mol Pharmacol; 2009 Dec; 76(6):1238-45. PubMed ID: 19779032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology and addiction.
    Tretter F; Gebicke-Haerter PJ; Albus M; an der Heiden U; Schwegler H
    Pharmacopsychiatry; 2009 May; 42 Suppl 1():S11-31. PubMed ID: 19434548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor inhibitors in cancer treatment: advances, challenges and opportunities.
    Modjtahedi H; Essapen S
    Anticancer Drugs; 2009 Nov; 20(10):851-5. PubMed ID: 19826350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.